These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17361979)

  • 1. Highly potent fluorescence-tagged nonimidazole histamine H3 receptor ligands.
    Amon M; Ligneau X; Camelin JC; Berrebi-Bertrand I; Schwartz JC; Stark H
    ChemMedChem; 2007 May; 2(5):708-16. PubMed ID: 17361979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescent non-imidazole histamine H3 receptor ligands with nanomolar affinities.
    Amon M; Ligneau X; Schwartz JC; Stark H
    Bioorg Med Chem Lett; 2006 Apr; 16(7):1938-40. PubMed ID: 16434192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor-specific functional efficacies of alkyl imidazoles as dual histamine H3/H4 receptor ligands.
    Kottke T; Sander K; Weizel L; Schneider EH; Seifert R; Stark H
    Eur J Pharmacol; 2011 Mar; 654(3):200-8. PubMed ID: 21237145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piperidine variations in search for non-imidazole histamine H(3) receptor ligands.
    Łazewska D; Kuder K; Ligneau X; Schwartz JC; Schunack W; Stark H; Kieć-Kononowicz K
    Bioorg Med Chem; 2008 Sep; 16(18):8729-36. PubMed ID: 18774720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural variations of 1-(4-(phenoxymethyl)benzyl)piperidines as nonimidazole histamine H3 receptor antagonists.
    Mikó T; Ligneau X; Pertz HH; Arrang JM; Ganellin CR; Schwartz JC; Schunack W; Stark H
    Bioorg Med Chem; 2004 May; 12(10):2727-36. PubMed ID: 15110854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Search for histamine H(3) receptor ligands with combined inhibitory potency at histamine N-methyltransferase: omega-piperidinoalkanamine derivatives.
    Grassmann S; Apelt J; Ligneau X; Pertz HH; Arrang JM; Ganellin CR; Schwartz JC; Schunack W; Stark H
    Arch Pharm (Weinheim); 2004 Oct; 337(10):533-45. PubMed ID: 15476285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclopropane-based stereochemical diversity-oriented conformational restriction strategy: histamine H3 and/or H4 receptor ligands with the 2,3-methanobutane backbone.
    Watanabe M; Kobayashi T; Hirokawa T; Yoshida A; Ito Y; Yamada S; Orimoto N; Yamasaki Y; Arisawa M; Shuto S
    Org Biomol Chem; 2012 Jan; 10(4):736-45. PubMed ID: 22120611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diether derivatives of homo- or substituted piperidines as non-imidazole histamine H3 receptor ligands.
    Łazewska D; Kuder K; Ligneau X; Camelin JC; Schunack W; Stark H; Kieć-Kononowicz K
    Bioorg Med Chem; 2009 Apr; 17(8):3037-42. PubMed ID: 19329325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New 1-benzyl-4-hydroxypiperidine derivatives as non-imidazole histamine H3 receptor antagonists.
    Maslowska-Lipowicz I; Figlus M; Zuiderveld OP; Walczynski K
    Arch Pharm (Weinheim); 2008 Dec; 341(12):762-73. PubMed ID: 19009544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acidic elements in histamine H(3) receptor antagonists.
    Sander K; von Coburg Y; Camelin JC; Ligneau X; Rau O; Schubert-Zsilavecz M; Schwartz JC; Stark H
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1581-4. PubMed ID: 20138762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragment based design of new H4 receptor-ligands with anti-inflammatory properties in vivo.
    Smits RA; Lim HD; Hanzer A; Zuiderveld OP; Guaita E; Adami M; Coruzzi G; Leurs R; de Esch IJ
    J Med Chem; 2008 Apr; 51(8):2457-67. PubMed ID: 18357976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorinated non-imidazole histamine H3 receptor antagonists.
    Isensee K; Amon M; Garlapati A; Ligneau X; Camelin JC; Capet M; Schwartz JC; Stark H
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2172-5. PubMed ID: 19286376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diamine derivatives containing imidazolidinylidene propanedinitrile as a new class of histamine H3 receptor antagonists. Part I.
    Sasho S; Seishi T; Kawamura M; Hirose R; Toki S; Shimada JI
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2288-91. PubMed ID: 18353639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the binding distribution of agonist and antagonist ligands for histamine H3 receptors in pig brain by quantitative autoradiography.
    Mezzomo K; Cumming P; Minuzzi L
    Eur J Pharmacol; 2007 Jun; 564(1-3):75-9. PubMed ID: 17350614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2,4-Diaminopyrimidines as histamine H4 receptor ligands--Scaffold optimization and pharmacological characterization.
    Sander K; Kottke T; Tanrikulu Y; Proschak E; Weizel L; Schneider EH; Seifert R; Schneider G; Stark H
    Bioorg Med Chem; 2009 Oct; 17(20):7186-96. PubMed ID: 19773175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tritium-labeled N(1)-[3-(1H-imidazol-4-yl)propyl]-N(2)-propionylguanidine ([(3)H]UR-PI294), a high-affinity histamine H(3) and H(4) receptor radioligand.
    Igel P; Schnell D; Bernhardt G; Seifert R; Buschauer A
    ChemMedChem; 2009 Feb; 4(2):225-31. PubMed ID: 19101971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diether (substituted) piperidine derivatives as novel, histamine H3 receptor ligands.
    Kuder KJ; Ligneau X; Camelin JC; Lazewska D; Schwartz JC; Schunack W; Stark H; Kieć-Kononowicz K
    Inflamm Res; 2009 Apr; 58 Suppl 1():47-8. PubMed ID: 19266264
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity.
    Morini G; Comini M; Rivara M; Rivara S; Bordi F; Plazzi PV; Flammini L; Saccani F; Bertoni S; Ballabeni V; Barocelli E; Mor M
    Bioorg Med Chem; 2008 Dec; 16(23):9911-24. PubMed ID: 18976927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-imidazole histamine H3 ligands, part IV: SAR of 1-[2-thiazol-5-yl-(2-aminoethyl)]-4-n-propylpiperazine derivatives.
    Frymarkiewicz A; Walczyński K
    Eur J Med Chem; 2009 Apr; 44(4):1674-81. PubMed ID: 18990469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azole derivatives as histamine H3 receptor antagonists, part I: thiazol-2-yl ethers.
    Walter M; von Coburg Y; Isensee K; Sander K; Ligneau X; Camelin JC; Schwartz JC; Stark H
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5879-82. PubMed ID: 20728354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.